Skip to content

Multicenter study of different doses of esketamine in painless gastroscope and colonoscopy or colonoscopy patients

Multicenter study of different doses of esketamine in painless gastroscope and colonoscopy or colonoscopy patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048556
Enrollment
Unknown
Registered
2021-07-10
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastrointestinal endoscopy

Interventions

Control group:After administering 5ug of sufentanil for 1 min, inject propofol at a rate of 0.5ml/min until the patient lost consciousness, and 5ml of propofol was added intraoperatively as needed
Experimental group1:After administering 0.05mg/kg of esesketamine for 1 min, inject propofol at a rate of 0.5ml/min until the patient lost consciousness, and 5ml of propofol was added intraoperative
Experimental group2:After administering 0.10mg/kg of esesketamine for 1 min, inject propofol at a rate of 0.5ml/min until the patient lost consciousness, and 5ml of propofol was added intraoperatively
Experimental group3:After administering 0.15mg/kg of esesketamine for 1 min, inject propofol at a rate of 0.5ml/min until the patient lost consciousness, and 5ml of propofol was added intraoperatively

Sponsors

Rizhao Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. ASA I~II; 2. Aged 18 to 60 years; 3. All patients had no mental or neurological disorders before surgery; 4. Good heart, lung, liver and kidney functions; 5. Activity equivalent > 4MET.

Exclusion criteria

Exclusion criteria: 1. Preoperative oral sedatives and antidepressants; 2. Preoperative assessment of difficult airway; 3. Patients with Mallampati grade > III.

Design outcomes

Primary

MeasureTime frame
Anesthesia effect;Respiratory changes;Changes in hemodynamics;The recovery time;Awake score;Patient satisfaction;

Secondary

MeasureTime frame
Application dose of propofol;

Countries

China

Contacts

Public ContactXu Jiping

Rizhao Central Hospital

rzhwfxjp@163.com+86 13792045179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026